Skip to main content

APS Biogroup Recalls Viralox, DPS Throat Spray, Immulox, and Immuno PRP Spray, Because of Possible Health Risk

Audience: Consumer, Health Professional, Pharmacy

June 13, 2019 -- APS BioGroup, Inc., of Phoenix, Arizona is recalling the following products:

Product Name UPC # Expiration Date
Sovereign Laboratories Viralox 8 63784 00015 0 04/2021
Pure Research Products DPS
Throat Spray
8 55602 00021 3 04/2021
NuMedica Immuno PRP Spray 8 12527 01176 2 04/2021
Nutrasumma Immulox 1 82863 000064 6 04/2021

These products are being recalled because they have the potential to be contaminated with Stenotrophomonas maltophilia. Stenotrophomonas maltophilia is a gram-negative bacteria that can cause respiratory infection, particularly in immunocompromised individuals.

The recalled products are dietary supplements for supporting immune health and were distributed nationwide and in Switzerland. The products were sold online, including on Amazon, direct-to- consumer, and to the following retail establishments: Sprouts #205 – Claremont, CA; Sprouts #020 – Tempe, AZ; and Healthy Habit Health Foods, Phoenix, AZ.

The products come in 5 ounce plastic spray bottles marked with lot # 9068. The labels associated with each product are attached.

No illnesses have been reported to date in connection with this problem.

The potential for contamination was discovered after routine testing by the company detected elevated Aerobic Plate Counts in samples of the product that had been retained by APS BioGroup. After completing additional testing, APS BioGroup determined that the products described above may be contaminated with Stenotrophomonas maltophilia

Consumers who have purchased the affected product are encouraged to immediately stop using the product. Consumers with questions may contact the company identified on the label to return the product and for an immediate refund. You may also contact APS BioGroup at 1-720-443-5030 from 9:00AM – 5:00PM MDT, Monday through Friday, for additional information.

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.